Comment on "Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"

Ejemplares similares

• Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System
  por: Wei, Chunyan, et al.
  Publicado: (2023)
• Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
  por: Liang, Yankun, et al.
  Publicado: (2023)
• Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
  por: Wang, Feifei, et al.
  Publicado: (2023)
• Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system
  por: Wu, Ziyang, et al.
  Publicado: (2022)
• Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
  por: Shu, Yamin, et al.
  Publicado: (2023)